Mitochondrial Dysfunction in Phelan-McDermid Syndrome

计划入组 51 人 · 首次发布于 2013 年 12 月 3 日

Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome

计划入组 18 人 · 首次发布于 2016 年 3 月 16 日

Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)

计划入组 19 人 · 首次发布于 2012 年 2 月 3 日

Phelan-McDermid Syndrome(Ksilink)

SHANK3 gene therapy (Phelan McDermid syndrome)

SHANK3 gene therapy (AAV, Phelan McDermid syndrome)

ALPORT SYNDROME FOUNDATION

United States

RETT SYNDROME RESEARCH TRUST

United States

International Rett Syndrome Foundation

United States

EMA Clears Oryzon's HOPE-2 Phase IIa Trial of Vafidemstat in Phelan-McDermid Syndrome

FDA Grants Orphan Drug Designation to NeuroNOS for Phelan-McDermid Syndrome Treatment

Neuren Pharmaceuticals Launches First-Ever Phase 3 Trial for Phelan-McDermid Syndrome